Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Dose Block-randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose, Phase I Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of JW1601

Trial Profile

A Dose Block-randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose, Phase I Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of JW1601

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 18 Feb 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Izuforant (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions
  • Sponsors JW Pharmaceutical

Most Recent Events

  • 11 Feb 2020 Status changed from recruiting to completed.
  • 27 Aug 2019 Results of the single-dose phase of this study published in the LEO Pharma media release.
  • 27 Aug 2019 According to a LEO Pharma media release, the company announced that the single-dose phase for this study has been completed with acceptable safety and tolerability observed up to the highest dose, 5th cohort.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top